30
Baylor Scott & White Heart and Vascular Hospital – Dallas Interventional Cardiology
Chronic total occlusion stenting
Baylor Scott & White Heart and Vascular Hospital – Dallas is a regional and national referral center for high-risk patients seeking treatment for totally occluded arteries with chronic total occlusion ( CTO ) stenting . An option to bypass surgery , the hospital is among a handful of medical facilities in Texas offering this service to address coronary obstructions . In addition to being one of the highest volume CTO cardiac centers in the nation , the hospital is also dedicated to research and innovation .
Baylor Scott & White Heart and Vascular Hospital – Dallas is participating in the CTO Progress Registry , a national database of elite cardiac centers nationwide that share data to identify best practices and best outcomes . Patients benefit from CTO related studies including various research trials to drive innovation . The hospital ’ s participation in the registry differentiates the program ’ s capabilities from many others .
Chronic total occlusions ( FY20 ):
78
Endovascular system
In fiscal year 2020 , interventional cardiologists on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Dallas continued to use the new endovascular system to treat pulmonary embolism and deep vein thrombosis . The approach helps improve the efficiency of the thrombolytic process and reduce the treatment time and total lytic dose , thereby reducing the associated bleeding risk and overall cost of therapy . The system enables ultrasound facilitated , controlled and selective infusion of physician-specified fluids , including thrombolytics , into the vasculature for the treatment of pulmonary embolism . This technology is intended for the treatment of pulmonary embolism patients with ≥50 % clot burden in one or both main pulmonary arteries or lobar pulmonary arteries and evidence of right heart dysfunction based on right heart pressures ( mean pulmonary artery pressure ≥25 mmHg ) or echocardiographic evaluation .
Shockwave Coronary Intravascular Lithotripsy System ® – Peripheral Use and Coronary Clinical Trial
Interventional cardiologists and vascular surgeons on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Dallas were several of the first specialists in North Texas to use the Shockwave Intravascular Lithotripsy System ® ( IVL ) to treat peripheral artery disease .
The peripheral IVL System that is already approved for use is effective in addressing the most difficult to treat patients with intimal and deep wall medial calcium . The IVL System has sizes capable of treating above and below the knee and is also being used in patients with heavily calcified iliac arteries in order to facilitate the transfemoral delivery of sophisticated devices in TAVR , EVAR and TEVAR and high-risk PCIs that require a left ventricular assist device . The new technology enables this patient group to benefit from this innovative technology when they would otherwise be ineligible for the procedure or would be at an increased risk for procedural complications .
Coronary use clinical trial Baylor Scott & White Heart and Vascular Hospital – Dallas began enrolling patients in a worldwide clinical trial to evaluate the safety and effectiveness of the Shockwave coronary intravascular lithotripsy system . The investigational technology uses a balloon catheter system designed to enhance stent outcomes by enabling delivery of the calcium disrupting capability of lithotripsy prior to balloon dilatation at low pressures . The single-use sterile catheter contains multiple lithotripsy emitters enclosed in an integrated balloon . The emitters create sonic pressure waves in the shape of a sphere , creating a field effect to disrupt and fracture calcium in the affected artery . For more information about the Disrupt CAD III Study with the Shockwave Coronary Intravascular Lithotripsy System
® , visit
BRITrials . BSWSites . com . Primary investigator : Robert Stoler , MD , FACC , FSCAI
Clinical Trials
Throughout the years , clinical trials have been a mainstay in the interventional cardiology arena at Baylor Scott & White Heart and Vascular Hospital – Dallas .